Pfizer conducts survey of French patients on information provided by industry

BMJ 2007; 334 doi: (Published 17 May 2007) Cite this as: BMJ 2007;334:1027
  1. Barbara Mintzes
  1. Amsterdam

    Pfizer's French headquarters is surveying groups of patients in France on whether legal restrictions in Europe on the types of information that drug companies can provide to patients should be lifted.

    Some health experts see the survey as part of a push by the drug industry to allow direct advertising of drugs to European consumers.

    The six question survey, which has been criticised for being biased, begins by asking whether patients believe that health information “can be distributed only by public institutions” and goes on to ask whether the law prohibiting companies from mentioning the name and the characteristics …

    View Full Text

    Sign in

    Log in through your institution